Holze F

Department of Clinical Research, Division of Clinical Pharmacology & Toxicology, Psychopharmacology Research, University Hospital Basel, and University of Basel, Basel, Switzerland.

Holze F

Psychedelics Restructure the Global Workspace of Consciousness

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants

Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Molecular, haemodynamic and functional effects of LSD in the human brain

Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study.

Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Treatment of neuropathic pain with repeated low-dose MDMA: a case report.

Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials.

Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up.

Safety pharmacology of acute psilocybin administration in healthy participants.

Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants.

Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.

Dosing Psychedelics and MDMA.

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.

Safety pharmacology of acute LSD administration in healthy subjects.

Role of the 5-HT<sub>2A</sub> Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin.

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis.

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects.

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.